Tyrosine and serine/threonine kinase activity profiling
Ended Purchase Order Awarded Last action
- Contract number
- 75N91021P00442
- Awardee
-
Pamgene International B.V. UEI DVBJJ8WMJ3M3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,000
Award facts
- Contract value 100% obligated
- $14,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Netherlands
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Pamgene International B.V. valued at $14,000.00 on May 17, 2021, for tyrosine and serine/threonine kinase activity profiling. Performance takes place in the Netherlands, with completion scheduled for June 5, 2021. The order is firm fixed price with no small business set-aside.
Quick answers
Who was awarded contract 75N91021P00442?
75N91021P00442 was awarded to Pamgene International B.V. by National Cancer Institute (National Institutes of Health) on May 17, 2021.
How much is contract 75N91021P00442 worth?
The government has obligated $14,000 on 75N91021P00442.
Was contract 75N91021P00442 competed?
The extent of competition for 75N91021P00442 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award